MGMT and neoplasm: In their seminal study regarding the impact of glioblastoma MGMT promoter methylation status on patterns of failure, Brandes et al. [30] demonstrated that MGMT promoter methylated tumours had a higher propensity for failure outside the radiotherapy field (42% of cases compared to 15% of unmethylated tumours).